GPCR · Structure Therapeutics Inc. · Executive Compensation

$41.23 +0.85 (+2.11%) At close · Sep 9

Market Cap

$3.17B

71.31M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Raymond Stevens	Chief Executive Officer and Director	$672,094	—	$2,387,996	$4,846,926	$508,871	$14,000	$8,429,887
Jun Yoon	Chief Financial Officer	$530,530	—	$1,193,998	$2,423,463	$309,075	$10,529	$4,467,595
Blai Coll	M.D., Ph.D. Chief Medical Officer	$492,813	—	$820,866	$1,666,117	$253,151	$14,000	$3,246,947
Xichen Lin	Chief Scientific Officer	$505,313	—	$567,150	$1,151,143	$257,103	—	$2,480,709
Yingli Ma	Chief Technology Officer	$429,768	—	$447,734	$908,788	$212,592	—	$1,998,882

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Raymond Stevens	Chief Executive Officer and Director	$634,246	—	$1,582,514	$3,173,843	$334,447	$13,800	$5,738,850
Xichen Lin	Chief Scientific Officer	$476,542	—	$1,007,057	$2,019,700	$185,799	$1,668	$3,690,766
Blai Coll	M.D., Ph.D. Chief Medical Officer	$449,138	—	$1,296,452	$1,504,500	$187,150	$13,800	$3,451,040
Jun Yoon	Chief Financial Officer	$482,300	—	$698,761	$1,401,433	$217,068	$13,800	$2,813,362

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Raymond Stevens	Chief Executive Officer and Director(4)	$595,852	—	—	$6,500,534	$281,325	$13,200	$7,390,911
Jun Yoon	Chief Financial Officer	$441,262	—	—	$3,047,125	$173,183	$13,200	$3,674,770
Mark Bach	M.D., Ph.D. Chief Medical Officer	$485,812	—	—	—	$173,045	$13,200	$672,057

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Raymond Stevens	Chief Executive Officer and Director(4)	$487,333	—	—	—	$247,500	$12,500	$747,333
Mark Bach	M.D., Ph.D. Chief Medical Officer	$466,375	—	—	—	$149,499	$12,500	$628,374

Executive changes

Person	Role	Change	Effective	Filed
Matthew Lang	Chief Operating Officer and General Counsel	Appointed	2026-04-15	2026-04-15
Matthew Lang	Chief Operating Officer and General Counsel	Appointed	2026-04-15	2026-04-15

Key facts CIK 1888886 CUSIP 86366E106 13F (30d) 135 filings 135 filers Visit website Investor relations